FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’
The US Food and Drug Administration’s (FDA’s) drug review agency has initiated a crackdown on e-commerce sites selling illicit ketamine…
News
Kalohexis confidentially files IPO to back obesity and cachexia portfolio
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
FDA grants rare paediatric designation to Vanda’s CMT2S therapy
Biocytogen and Whitehawk partner to develop ADCs
Merck KGaA-backed Cyllene Therapeutics secures €33m for gene therapy pipeline
Vertex signs agreement to acquire Crinetics for $10bn
EC approves AbbVie’s Tepkinly combination for follicular lymphoma
